image
DiaMedica Therapeutics Inc. DMAC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.86
-3.5 %
$ 165 M
Market Cap
-6.43
P/E
CASH FLOW STATEMENT
-22.1 M OPERATING CASH FLOW
-17.88%
Growth Rates
1Year -17.88%
3Years -21.69%
5Years -19.39%
7Years -28.10%
10Years -19.38%
8.56 M INVESTING CASH FLOW
146.80%
Growth Rates
1Year 146.80%
3Years 34.20%
5Years 33.19%
7Years 134.61%
10Years 75.38%
12 M FINANCING CASH FLOW
-67.44%
Growth Rates
1Year -67.44%
3Years 635.97%
5Years 179.75%
7Years 19.05%
10Years 21.73%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DiaMedica Therapeutics Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -24.4 M
Depreciation & Amortization 39 K
Capital Expenditures -25 K
Stock-Based Compensation 2.08 M
Change in Working Capital 1.51 M
Others 97 K
Free Cash Flow -22.1 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004
OPERATING CASH FLOW
Net Income (24.4) (19.4) (13.7) (13.6) (12.3) (10.6) (5.7) (4.3) (2.2) (1.4) (4.8) (7.4) (10.1) (6.6) (4.3) (2.4) (1.9) (2.3) (0.8) (0.2) (0.6)
Depreciation & Amortization 39 K 30 K 25 K 24 K 21 K 21 K 15 K 4 K 2.2 K 4.11 K 2.47 K 1.1 2.4 2.3 1.7 30.2 K 26.7 K 18.4 K 3.32 K 28.2 K 6.41 K
Deferred Income Tax 0 0 0 0.2 4 K 74 K 0 84.6 K (0.2) 21.5 K (0.3) (0.7) (1.0) 0 (0.2) (0.3) (0.2) 0 0 0 0
Stock Based Compensation 2.1 1.7 1.5 1.6 1.8 1.2 0.6 0.4 0.3 0.1 0.3 0.7 1.0 0 0.3 0.3 0.2 0 0 0 0
Other Operating Activities (1.3) (1.2) 53 K 58 K 52 K 49 K 39 K 93.6 K 22.9 K 21.5 K 0.6 0.7 1.0 0.8 0.3 0.3 0.3 1.0 0 6.44 K 34 K
Change in Working Capital 1.5 93 K 0.6 (0.5) 1.2 0.4 (0.6) 44 K (0.9) 53 K 0.4 66.6 K 1.2 36.2 K (0.1) 35.6 K 41.7 K 0.1 26.5 K (0.7) 0.5
Cash From Operations (22.1) (18.7) (11.5) (12.3) (9.2) (9.1) (5.7) (3.9) (3.0) (1.4) (3.8) (5.5) (5.5) (3.4) (2.4) (2.1) (1.5) (1.2) (0.8) (0.8) 99.4 K
INVESTING CASH FLOW
Capital Expenditures 25 K 24 K 81 K 22 K 47 K 2 K 50 K 22 K 6.89 K 5.39 K 31.3 K (0.1) 63.4 K 79.3 K 57.8 K 92.1 K 85.3 K (0.3) (0.1) 77 K (0.1)
Other Items 8.6 (18.3) 11.6 (20.5) (16.1) (3.9) 0 0 0 0 0 0 0 0 149 0 0 0 0 0 0
Cash From Investing Activities 8.6 (18.3) 11.5 (20.5) (16.1) (3.9) 50 K 22 K 6.89 K 5.39 K 31.3 K (0.1) 63.4 K 79.3 K 57.6 K 92.1 K 85.3 K (0.3) (0.1) 77 K (0.1)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 9 K 6 K 6 K 6 K 5 K 5 K 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) 0.1
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.3 0 0 0.2 45 K 75 K 0.7 0.6 0.5 22.6 K 0.2 95.4 K 5.2 0.2 2.8 0 0 0 0 0.302 0
Cash From Financing Activities 12.0 36.8 6 K 30.1 K 28.8 70 K 21.2 3.5 4.6 1.4 1.7 6.0 5.2 3.4 4.6 0 1.2 4.7 0.9 1.2 0.2
CHANGE IN CASH
Net Change In Cash (3.2) (6.5) (22.7) (34.2) 76.2 12.9 (5.9)
FREE CASH FLOW
Free Cash Flow (104.1) (114.3) (104.1) (73.0) (51.0) (20.3) (5.9)